# US 2025/0082631 A1 · Sleep improving agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082631 A1
- Document ID: US20250082631A1
- Status: Published application
- Kind: A1
- Application number: 18/955,623
- Filed: 2024-11-21
- Published: 2025-03-13
- Earliest claimed: 2016-05-26
- Assignees: Amino Up Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.
- Applicants: Amino Up Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.
- Inventors: Kazunori GOTO; Jun Nakahigashi; Atsuya Sato; Yosuke Hirayama; Moeri Horikoshi; Noriyuki Kouda; Syoichiro Inoue; Ikutaro Sato; Manami Kato
- Web page: https://patentgrep.com/patent/US20250082631A1

## CPC

- A61K 31/4985: Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A61P 25/20: Hypnotics; Sedatives
- A61P 25/22: Anxiolytics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided is a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.

## Claims

### Claim 1

A method for anti-stressing, which comprises administrating a compound represented by formula (I):
wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof to a subject.

### Claim 2 (depends on 1)

The method according to claim 1, wherein R is isopropyl, phenyl, or hydroxyphenyl.

### Claim 3 (depends on 1)

The method according to claim 1, wherein R is isopropyl.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the compound or a salt thereof is administrated to the subject in the form of a pharmaceutical composition, or food and beverage composition.
